Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
Clinical trial NCT00427583 · TERMINATED
Trial details
- NCT number
- NCT00427583
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-04-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.